These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28266705)

  • 41. Impact of parenchymal preserving surgery on survival and recurrence after liver resection for colorectal liver metastasis.
    Pandanaboyana S; Bell R; White A; Pathak S; Hidalgo E; Lodge P; Prasad R; Toogood G
    ANZ J Surg; 2018 Jan; 88(1-2):66-70. PubMed ID: 27111217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Resection of liver metastases from colorectal cancer: the real impact of the surgical margin.
    Elias D; Cavalcanti A; Sabourin JC; Lassau N; Pignon JP; Ducreux M; Coyle C; Lasser P
    Eur J Surg Oncol; 1998 Jun; 24(3):174-9. PubMed ID: 9630855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of novel histopathological factors on the outcomes of liver surgery for colorectal cancer metastases.
    Serrablo A; Paliogiannis P; Pulighe F; Moro SS; Borrego-Estella V; Attene F; Scognamillo F; Hörndler C
    Eur J Surg Oncol; 2016 Sep; 42(9):1268-77. PubMed ID: 26947960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of microscopically margin-positive resection on survival in children with hepatoblastoma after hepatectomy: a retrospective cohort study.
    Ren X; Li H; Diao M; Xu H; Li L
    Int J Clin Oncol; 2020 Apr; 25(4):765-773. PubMed ID: 31701290
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The clinical relevance of the Fong and the Nordlinger scores in the era of effective neoadjuvant chemotherapy for colorectal liver metastasis.
    Schreckenbach T; Malkomes P; Bechstein WO; Woeste G; Schnitzbauer AA; Ulrich F
    Surg Today; 2015 Dec; 45(12):1527-34. PubMed ID: 25563588
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microscopic biliary and perineural invasion and clinical outcome after neoadjuvant bevacizumab-based chemotherapy and liver resection in patients with colorectal liver metastases.
    Stift J; Graf A; Schwarz C; Tamandl D; Starlinger P; Herac M; Beer A; Wrba F; Bodingbauer M; Kaczirek K; Stremitzer S
    Eur J Surg Oncol; 2018 Jan; 44(1):139-147. PubMed ID: 29203074
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perioperative chemotherapy with or without bevacizumab in patients with metastatic colorectal cancer undergoing liver resection.
    Constantinidou A; Cunningham D; Shurmahi F; Asghar U; Barbachano Y; Khan A; Mudan S; Rao S; Chau I
    Clin Colorectal Cancer; 2013 Mar; 12(1):15-22. PubMed ID: 23021126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases.
    Reddy SK; Morse MA; Hurwitz HI; Bendell JC; Gan TJ; Hill SE; Clary BM
    J Am Coll Surg; 2008 Jan; 206(1):96-106. PubMed ID: 18155574
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of Neoadjuvant Chemotherapy in Patients with Colorectal Cancer Liver Metastases.
    Sui K; Okabayashi T; Iwata J; Morita SM; Matsumoto T; Inada R; Iiyama T; Shimada Y; Kobayashi M
    Surg Technol Int; 2019 May; 34():208-214. PubMed ID: 31037714
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 'Close shave' in liver resection for colorectal liver metastases.
    Lordan JT; Karanjia ND
    Eur J Surg Oncol; 2010 Jan; 36(1):47-51. PubMed ID: 19502001
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk Factors for Unresectable Recurrence After Up-Front Surgery for Colorectal Liver Metastasis.
    Hokuto D; Nomi T; Yasuda S; Yoshikawa T; Ishioka K; Yamada T; Akahori T; Nakagawa K; Nagai M; Nakamura K; Obara S; Kanehiro H; Sho M
    World J Surg; 2018 Mar; 42(3):884-891. PubMed ID: 28879511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.
    Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM
    Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients.
    Viganò L; Capussotti L; Lapointe R; Barroso E; Hubert C; Giuliante F; Ijzermans JN; Mirza DF; Elias D; Adam R
    Ann Surg Oncol; 2014 Apr; 21(4):1276-86. PubMed ID: 24346766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liver resection for colorectal cancer metastases involving the caudate lobe.
    Thomas RL; Lordan JT; Devalia K; Quiney N; Fawcett W; Worthington TR; Karanjia ND
    Br J Surg; 2011 Oct; 98(10):1476-82. PubMed ID: 21755500
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The prognostic value of the primary tumor’s nodal status after surgery for colorectal liver metastases in the era of effective systemic therapy.
    van der Stok EP; Grünhagen DJ; Alberda WJ; Reitsma M; Rothbarth J; Verhoef C
    Dig Surg; 2015; 32(3):208-16. PubMed ID: 25896431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail.
    Hank T; Hinz U; Tarantino I; Kaiser J; Niesen W; Bergmann F; Hackert T; Büchler MW; Strobel O
    Br J Surg; 2018 Aug; 105(9):1171-1181. PubMed ID: 29738626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of R1 resection for colorectal liver metastases on local recurrence and overall survival in the era of modern chemotherapy: An analysis of 1,428 resection areas.
    Ardito F; Panettieri E; Vellone M; Ferrucci M; Coppola A; Silvestrini N; Arena V; Adducci E; Capelli G; Vecchio FM; Giovannini I; Nuzzo G; Giuliante F
    Surgery; 2019 Apr; 165(4):712-720. PubMed ID: 30482518
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of the surgeon as a variable in long-term survival after liver resection for colorectal metastases.
    Giuliante F; Ardito F; Vellone M; Ranucci G; Federico B; Giovannini I; Nuzzo G
    J Surg Oncol; 2009 Dec; 100(7):538-45. PubMed ID: 19722234
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases.
    Capussotti L; Muratore A; Mulas MM; Massucco P; Aglietta M
    Br J Surg; 2006 Aug; 93(8):1001-6. PubMed ID: 16739103
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peri-operative chemotherapy for resectable colorectal liver metastasis: does timing of systemic therapy matter?
    Pinto Marques H; Barroso E; de Jong MC; Choti MA; Ribeiro V; Nobre AM; Carvalho C; Pawlik TM
    J Surg Oncol; 2012 May; 105(6):511-9. PubMed ID: 22065486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.